Press releases

Month Year

Email alerts

Feb 29, 2012

Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints

World’s First Insulin Pump with Low Glucose Suspend Showed Reduces Time Spent in Low Threshold Range

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 29, 2012-- In the next step toward the development of an artificial pancreas, Medtronic, Inc. (NYSE:MDT) today announced that the results of the in-clinic ASPIRE...
Feb 23, 2012

Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 23, 2012-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Citi Healthcare Conference...
Feb 21, 2012

Medtronic Reports Third Quarter Earnings

Revenue of $3.9 Billion Driven by International Revenue Growth of 6% on a Constant Currency Basis, 7% as Reported

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 21, 2012-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2012, which ended January 27, 2012. The company...
Feb 17, 2012

Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease

Distinguished by Superior Deliverability and Diabetes Indication, New Heart Device Becomes Available to Cath Labs Nationwide

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 17, 2012-- Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (
Feb 16, 2012

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2012

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 16, 2012-- The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.2425 per share of the Company’s common stock. The dividend...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa